Izixhobo ze-Gastroenterology i-Endoscopic Sclerotherapy inaliti
Izixhobo ze-Gastroenterology i-Endoscopic Sclerotherapy inaliti
Isicelo
Inaliti ye-ZRHED® ye-Sclerotherapy yenzelwe ukuba isetyenziselwe inaliti ye-endoscopic ye-Scleopic ye-ScleOtherapy Agents Agents kunye ne-Dyes ukuya kwi-Esophagege okanye ii-colophal ezahlukeneyo. Ikwaboniswa nokutsala i-saline ukuze incedise kwi-Endosial Rection Rection (Emr) kunye neenkqubo zePolypectomy. Inaliti ye-saline ukuze incedise kwi-Endoscopic Rection Rection Puttion (Emr), iinkqubo zePolypectomy kunye nokulawula i-haemorrhage engafaniyo.
Ukucaciswa
| Imodeli | Sheath od ± 0.1 (mm) | Ubude bokusebenza l ± 50 (mm) | Ubungakanani benaliti (ububanzi / ubude) | I-Endoscopic Channel (MM) |
| Zrh-pn-2418-2141414 | Φ2.4 | I-1800 | I-21g, 4mm | ≥2.8 |
| Zrh-pn-2418-234 | Φ2.4 | I-1800 | 23G, 4mm | ≥2.8 |
| Zrh-pn-2418-254 | Φ2.4 | I-1800 | I-25g, i-4mm | ≥2.8 |
| Zrh-pn-2418-216 | Φ2.4 | I-1800 | I-21g, i-6mm | ≥2.8 |
| Zrh-pn-2418-236 | Φ2.4 | I-1800 | 23G, 6mm | ≥2.8 |
| Zrh-pn-2418-256 | Φ2.4 | I-1800 | I-25g, i-6mm | ≥2.8 |
| Zrh-pn-2423-214141414 | Φ2.4 | 2300 | I-21g, 4mm | ≥2.8 |
| Zrh-pn-2423-234 | Φ2.4 | 2300 | 23G, 4mm | ≥2.8 |
| Zrh-pn-2423-254 | Φ2.4 | 2300 | I-25g, i-4mm | ≥2.8 |
| Zrh-pn-2423-216 | Φ2.4 | 2300 | I-21g, i-6mm | ≥2.8 |
| Zrh-pn-2423-236 | Φ2.4 | 2300 | 23G, 6mm | ≥2.8 |
| Zrh-pn-2423-256 | Φ2.4 | 2300 | I-25g, i-6mm | ≥2.8 |
Inkcazo yeMveliso
Inaliti ingelosi ingelosi 30 Inqanaba
Ukugoba ubukhali
Ityhubhu yangaphakathi ebonakalayo
Inokusetyenziselwa ukugcina igazi.
Ulwakhiwo lomeleleyo
Ukuququzelelwa kwenkqubela phambili ngokusebenzisa iindlela ezinzima.
I-ERDOGIC Par
Kulula ukulawula inaliti ihamba.
Indlela Inaliti ye-Scleiratherapy isebenza ngayo
Inaliti ye-sclerotherapy isetyenziselwa ukuthintela ulwelo kwindawo ye-submucosal yokuphakamisa i-lesion kude kwi-procria ye-muscroculas kwaye wenze ithagethi engaphantsi kophando.
Indlela yokuphakamisa kunye nokusika i-endoscopic ye-mucosal.
.
Inaliti ye-sclerotherapy isetyenziselwa ukuthintela ulwelo kwindawo ye-submucosal yokuphakamisa i-lesion kude kwi-procria ye-muscroculas kwaye wenze ithagethi engaphantsi kophando. Inaliti ihlala yenziwa nge-saline, kodwa ezinye izisombululo zisetyenziselwe ukufezekisa ukulungiswa kwexesha kubandakanya i-hypernon, i-20] i-dextrase [2]. I-Indigo Carmine (i-0.004%) okanye i-methylene iluhlaza okwesibhakabhaka ihlala yongezwa kwi-Instice yokubeka i-submucosa kwaye ibonelele ngovavanyo olungcono lobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bobunzulu bendawo. Inaliti ye-submucosal inokusetyenziselwa ukufumanisa ukuba i-lesion ilungile kwi-endoscopic. Ukunqongophala kokuphakama ngexesha lentsingiselo kubonisa ukubambelela kwi-procria ye-muscroulis kwaye sisivumelwano esichaseneyo sokuqhubeka ne-EMR. Emva kokudala ukuphakanyiswa kwe-submucossal, isilonda sibambekile nge-raties ye-rat edluliselwe kwi-Polypectomy evulekileyo. Amandla aphakamisa isilonda kunye nomgibe ukutyhalwa phantsi ngokujikeleza isiseko sayo kunye nokuqhubela phambili. Le ndlela "ifikelela-" ngokusebenzisa "ifuna i-Endoscope ephindwe kabini ye-lumen enokubangela ukuba isebenzise i-esophagus. Ngenxa yoko, iindlela zokuphakamisa kunye nokusika zisetyenziswa kancinci kwizilonda ze-esophagegeal.
